Watermeadow supports charity cycle ride
January 13, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Watermeadow is the proud sponsor of a team of Burford fire fighters and their colleagues who cycled 983 miles from …
Hanne Leth Hillman joins Zealand Pharma
January 13, 2011Medical Communications Hanne Leth Hillman, Zealand Pharma, appointment, medical communications
Danish biopharmaceutical company Zealand Pharma has appointed Hanne Leth Hillman as VP of investor relations and corporate communications. She will …
Aurobindo sells Chinese API unit to Sinopharm
January 13, 2011Manufacturing and Production API, Aurobindo Pharma, China, Sinopharm Weiqida Pharmaceutical, active pharmaceutical ingredient
Indian company Aurobindo Pharma intends to sell off a loss-making active pharmaceutical ingredient unit to Sinopharm, the largest pharmaceutical company …
Learning from other healthcare models
January 13, 2011CapGemini, Kaiser Permanente, NHS, healthcare, integrated healthcare
When you need high quality healthcare that is also affordable, prevention is definitely better than cure. How can governments and …
Pfizer lung cancer drug gets ‘rolling’ fast-track status in US
January 13, 2011Sales and Marketing Cancer, NSCLC, axitinib, bosutinib, crizotinib, non-small cell lung cancer
Pfizer has initiated a ‘rolling’ submission for its new oral ALK lung cancer drug crizotinib that could see it on …
Czech reforms will cut drug spending
January 13, 2011Sales and Marketing Czech Republic, Drug pricing, drug funding, drug spending, global pricing, healthcare reforms, medicines pricing
The Czech Republic has announced a major healthcare reform plan, including plans to restrict access to high cost new medicines. …
New cancer strategy gets £750 million boost
January 13, 2011Cancer, NHS, cancer funding, cancer strategy
The government has published a new ‘Strategy for Cancer’ that seeks to increase preventive measures and improve outcomes for oncology …
Digital Pharma: Pfizer launches Dutch prescription service
January 12, 2011Medical Communications Digital Pharma blog, Holland, Pfizer, consumer healthcare, disease awareness campaigns, healthcare coaching, ilivi.nl, patient information
Pfizer has tied up with an online pharmacy to break new ground in patient services in Holland with ilivi.nl. The …
Amgen aims for oncology expansion and a wider denosumab license
January 12, 2011Research and Development AMG- 479, AMG-386, Amgen, Cancer, Pancreatic cancer, denosumab, motasenib
Amgen is seeking to increase the use of its bone drug denosumab and further its reach into the oncology market, …
Call to share public health research more openly
January 12, 2011Research and Development Bill and Melinda Gates Foundation, Wellcome Trust, data sharing, public health
The only way that pressing needs in global public health can be met is for research to be shared more …
Lilly and Boehringer sign major diabetes collaboration
January 12, 2011Research and Development BI10773, Boehringer Ingelheim, Eli Lilly, LY2605541, LY2963016, TGF-beta monoclonal antibody, diabetes, lilly, linagliptin, type II diabetes
Eli Lilly and Boehringer Ingelheim have signed a multi-million dollar collaboration that will see them develop and commercialise a mid- …
Dr Simon Thorn joins Spectrum Regulatory Solutions
January 12, 2011Research and Development Dr Simon Thorn, Specrum Regulatory Services, appointment, research and development
Spectrum Regulatory Solutions has appointed Dr Simon Thorn as a senior regulatory writer. He has more than 15 years experience …
Marketing authorisations for medicines: UK Decentralised Procedure slots available in all therapeutic areas in 2011
January 12, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The MHRA has reported it has RMS decentralised procedure slots available in 2011 for all therapeutic areas, including biologicals and …
Servier’s Mediator provokes French drug safety controversy
January 12, 2011Sales and Marketing AFSSAPS, France, Mediator, Servier, benfluorex, drug safety
Serious questions are being asked about drug safety monitoring in France in connection with Servier’s Mediator (benfluorex) which was withdrawn …
Regulatory assistance available to Small and Medium-sized Enterprises (SMEs)
January 12, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The increasing number of SMEs in Europe is seen to be a driving force to facilitate economic growth, new product …
Deadline approaching for cancelling UK Licences
January 12, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The MHRA has recently advised all holders of UK marketing authorisations, registrations and licences to inform them by the 31st …
Updated report on origins of clinical trial participants
January 12, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The European Medicines Agency has published an updated report detailing the geographical origins of patients included in clinical trials for …
Scientific Advice and Guidance Available
January 12, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
In April, we reported how a joint pilot scheme operated by the UK Medicines & Healthcare Products Regulatory Agency (MHRA), …
UK trade associations form new life sciences lobbying group
January 11, 2011Research and Development, Sales and Marketing ABHI, ABPI, BIA, BIVDA, LifeSciencesUK, lobbying
Four industry trade associations including pharma body the ABPI have banded together to form a new lobbying group representing life …
Savient plays down gout drug manufacturing problems
January 11, 2011Manufacturing and Production, Sales and Marketing Krystexxa, Savient, biologic manufacturing, gout, manufacturing compliance, pegloticase
Savient Pharmaceuticals has reported that some production batches of Krystexxa, its recently-approved second-line treatment for gout, have failed to meet …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
